Oral contraceptive use and the risk of chlamydial and gonococcal infections.
about
Innate immune defences in the human endometriumHormonal contraception, sexual behaviour and HIV prevalence among women in Cameroon.Neisseria gonorrhoeae survival during primary human cervical epithelial cell infection requires nitric oxide and is augmented by progesteroneA randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.Chlamydia trachomatis among sexually active teenage girls: influence of sampling location and clinical signs on the detection rate.Chlamydia trachomatis in sexually active teenage girls. Factors related to genital chlamydial infection: a prospective studyChlamydia trachomatis and oral contraceptive use: a quantitative review.Pathogenesis of pelvic inflammatory disease.Risk factors for gonorrhoea: case-control studyPreventing HIV infection in women: a global health imperative.Predictors of chlamydial infection and gonorrhea among patients seen by private practitionersHormonal contraception and area of cervical ectopy: a longitudinal assessment.Hormonal contraception and HIV-1 transmission.The Pathobiology of Neisseria gonorrhoeae Lower Female Genital Tract Infection.Vaginal douching: evidence for risks or benefits to women's health.Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South AfricaInfluence of ovarian hormones on urogenital infection.Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.Depot medroxyprogesterone acetate use is not associated with risk of incident sexually transmitted infections among adolescent women.A prospective study of genital infections in a family-planning clinic. 2. Chlamydia infection--the identification of a high-risk group.Contraception and HIV infection in women.Assessing the relationship between cervical ectopy and HIV susceptibility: implications for HIV prevention in women.Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research.A bill of health for the IUD: where do we go from here?Teenage healthEstrogens and glucocorticoids have opposing effects on the amount and latent activity of complement proteins in the rat uterus.
P2860
Q24801159-D57BAEE0-9390-4DC0-B89C-48460D6E9EFAQ33381415-D7491B3D-428F-474F-8B1A-3C99F1F19F79Q33676046-4BD73F85-358B-4B41-B16D-2E4EE25903CEQ33763511-85572129-49EB-48B7-A501-D30FBD3836F6Q33932500-3E9F404A-E19F-417B-8943-B0D4A2898CB0Q33933217-3F4CB1DB-4404-4296-9866-04E724A5F1F7Q33933701-51C385B2-1D96-4A2A-8FB8-55BB8291199EQ33934169-1CAD6FCA-7372-4C01-9301-F356CC32A6D7Q33937060-21E4502D-7FA8-4AF2-9374-A46477741E1DQ34495248-7307ADDB-BCBD-48B2-876B-AAD0182BF220Q34580154-353384BF-C720-48E4-A81D-6BF054F89582Q34675983-C0A2E7E2-E9C6-4521-B9BB-BD91AC8B6698Q34679705-E50E0957-7FF0-48F7-AC74-0064117120C5Q35084650-27DBBE42-C4FC-4AD1-81C0-520192E6765FQ35133838-6161DEE0-F864-437A-BFE2-E971BD2470EDQ35135860-7988A47B-94A7-4681-8C12-D73C2C44BD96Q35562045-CED35940-A5BB-4124-998C-C151F234736EQ35824139-C5EAA88B-591A-49BE-AB89-0F363848A05EQ36488387-94C761EF-1C23-4CA8-9234-CFCFEFB83CA3Q36504796-6253612B-F584-4987-9406-5FF9DFDBDAB8Q37090507-F5954394-5A71-4678-BDF5-A3FD5338E5A3Q38051420-0E5C2DDF-150A-41E9-BE74-684D97B49000Q38212118-CCE1E4CA-303E-4C07-9463-D86B38E8DC85Q41032486-E8114054-6F9F-4296-922E-1E1A5744B07AQ42546914-8B34CAB1-8ABC-4969-85D6-48306801DC28Q46750227-3AAFC024-5DA7-40B0-9A76-4ED58EB1F26D
P2860
Oral contraceptive use and the risk of chlamydial and gonococcal infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1989
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral contraceptive use and the risk of chlamydial and gonococcal infections.
@en
Oral contraceptive use and the risk of chlamydial and gonococcal infections.
@nl
type
label
Oral contraceptive use and the risk of chlamydial and gonococcal infections.
@en
Oral contraceptive use and the risk of chlamydial and gonococcal infections.
@nl
prefLabel
Oral contraceptive use and the risk of chlamydial and gonococcal infections.
@en
Oral contraceptive use and the risk of chlamydial and gonococcal infections.
@nl
P2093
P1476
Oral contraceptive use and the risk of chlamydial and gonococcal infections.
@en
P2093
P304
P356
10.1016/0002-9378(89)90456-0
P407
P577
1989-02-01T00:00:00Z